MNTA's ASCO abstract: http://abstracts.asco.org/156/AbstView_156_143720.html Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of necuparanib combined with nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer: Phase 1 results.